Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharma Production i Stockholm AB
AB
Active
Org 5567643209
Stockholm
Business and other management consultancy activities
· NACE 7020
Est. 2008
0 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Pharma Production i Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
4M
9M
13M
17M
12M
2021
12M
2022
12M
2023
12M
2024
15M
2025
EBITDA
SEK millions
0M
2M
5M
7M
9M
6M
2021
6M
2022
5M
2023
5M
2024
8M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
12 344
12 195
11 957
12 379
15 484
Staff expenses
—
—
—
—
—
EBITDA
6 395
5 604
4 695
4 620
8 347
Depreciation & amort.
−23
−17
−28
−33
−37
EBIT
6 372
5 587
4 667
4 587
8 310
Net financials
−24
−5
1
110
130
Profit before tax
103
−168
23
−450
1 638
Tax
−96
−7
−67
−0
−398
Net profit
7
−175
−44
−450
1 240
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
5 185
4 462
4 269
6 442
7 409
Equity
3 621
3 445
3 402
2 951
4 191
Long-term debt
400
0
0
0
0
Short-term debt
1 160
1 012
868
3 491
2 573
Total debt
1 560
1 012
868
3 491
2 573
Financial ratios
5-year trend
EBITDA margin
53.9%
This company
15.8%
Market median
+241% vs market
2021
2025
Equity ratio
56.6%
This company
38.2%
Market median
+48% vs market
2021
2025
Return on equity
29.6%
This company
18.4%
Market median
+61% vs market
2021
2025
Net profit margin
8.0%
This company
8.1%
Market median
-1% vs market
2021
2025
Asset turnover
2.09×
This company
1.12×
Market median
+87% vs market
2021
2025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Pharma Production i Stockholm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
